FDA approved KetoMed ketoprofen injectable solution for control of fever associated with bovine respiratory disease in several classes of cattle. FDA notes it is prescription-only and requires veterinary expertise to diagnose BRD and monitor safe use.
Three quick summaries of the same article, tailored for different readers.
FDA’s ketoprofen approval applies to fever associated with bovine respiratory disease in cattle under veterinary prescription. For pet owners, the takeaway is broader: never borrow animal medications across species. A drug that is appropriate for one species, dose, and disease can be inappropriate or dangerous in another.
Useful source for a timely veterinary news/research update and audience-specific teaching context.For vet techs and livestock teams, the update reinforces accurate signalment, indication, prescription status, and treatment records. Ketoprofen may help control pyrexia associated with BRD, but the case still needs veterinarian-directed diagnosis, monitoring, and herd-level thinking. Food-animal documentation also has residue and withdrawal implications that companion-animal workflows do not.
Useful source for a timely veterinary news/research update and audience-specific teaching context.Ketoprofen is an NSAID that inhibits prostaglandin production, which helps explain its anti-inflammatory and antipyretic effects. In BRD, however, fever is a clinical sign within a larger infectious and inflammatory syndrome. The reasoning distinction is important: reducing fever may improve comfort and support recovery, but it does not identify the pathogen, determine antimicrobial need, or replace herd-level prevention.
Useful source for a timely veterinary news/research update and audience-specific teaching context.